Smith Graham & Co Investment Advisors’s Diebold Nixdorf Incorporated DBD Stock Holding History
Bought
Maintained
Sold
Other funds holding DBD
BPCM
GI
SI
AA
Smith Graham & Co Investment Advisors's DBD Position: Q2 2022 in Review
Smith Graham & Co Investment Advisors sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2022, closing a stake of 1,142,249 shares — an estimated $7.69M sold.
Smith Graham & Co Investment Advisors first reported a position in DBD in Q4 2017 and held it in 18 quarters. The position peaked at $18.7M in Q1 2021. 169 funds tracked by Wall St. Rank hold DBD as of Q2 2022.
- Smith Graham & Co Investment Advisors reported no remaining Diebold Nixdorf Incorporated position as of Q2 2022 after selling out during the quarter.
- Smith Graham & Co Investment Advisors sold 1,142,249 Diebold Nixdorf Incorporated shares in Q2 2022, an estimated $7.69M.
- Smith Graham & Co Investment Advisors first reported a position in Diebold Nixdorf Incorporated in Q4 2017 and held it in 18 quarters.
- Smith Graham & Co Investment Advisors's Diebold Nixdorf Incorporated position peaked at $18.7M in Q1 2021.
- 169 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2022.
Based on Smith Graham & Co Investment Advisors's 13F filing for Q2 2022, filed 4 Aug 2022.